COMMUNIQUÉS West-GlobeNewswire

Ipsen - Février 2026 - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
13/03/2026
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social (conformément à l’article L.233-8 II du Code de commerce et à l’article 223-16 du Règlement Général de l’ [...]
Novartis Cosentyx® receives FDA approval for pediatric patients aged 12+ with moderate to severe hidradenitis suppurativa
13/03/2026
Cosentyx is the only IL-17A inhibitor approved for this population, and the first differentiated mechanism in nearly a decade 1-3 HS often emerges around puberty, underscoring importance of early diagnosis and [...]
Tevogen.AI Reports Advancements in PredicTcell™ Beta, Demonstrates Improved Precision Metrics and Expands Proprietary AI Infrastructure
13/03/2026
WARREN, N.J., March 13, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ) today announced performance advancements for its artificial intelligence platform, operated through [...]
How Scientists Measure the Circulation You Actually Feel — Not Just the Arteries They Can See
13/03/2026
The Human Vascular System Stretches Up to 100,000 Miles — Standard Imaging Captures Only a Fraction of It The Endothelial Glycocalyx: A Microscopic Lining That Helps Regulate How Blood Moves Through the Smallest Vessels [...]
Prospective, Multi-center Study Published in Future Oncology Demonstrates DecisionDx®-Melanoma’s i31-SLNB Result Outperforms Staging Criteria in Identifying Patients with Cutaneous Melanoma Below the 5% NCCN Threshold for Forgoing SLNB
13/03/2026
Among all patients studied, 2.6% nodal positivity and 97.8% three-year recurrence-free survival (RFS) was observed in those predicted to have less than 5% risk of a positive sentinel lymph node (SLN) by DecisionDx- [...]
Disclosure of a transparency notification from Mawer Investment Management Ltd
13/03/2026
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 13 March 2026 – 6 PM CET Disclosure of a transparency notification from Mawer Investment Management Ltd Pursuant to the Belgian act of 2 May 2007 on [...]
Junshi Biosciences Announces 2025 Full Year Financial Results and Provides Corporate Updates
13/03/2026
SHANGHAI, March 13, 2026 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, [...]
Sana Biotechnology Announces Continued Positive Clinical Results Through 14 Months from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression
13/03/2026
Groundbreaking First-in-Human Study Demonstrates Potential to Treat Type 1 Diabetes by Transplanting Insulin-Secreting Cells Without Immunosuppression 14-Month Follow-up Data Show Hypoimmune (HIP)-Modified Islets are [...]
Elutia Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
13/03/2026
GAITHERSBURG, Md., March 13, 2026 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) ("Elutia" or the "Company"), a pioneer in drug-eluting biomatrix technologies, today announced that it granted equity awards on March 10, [...]
23andMe Introduces Reconstructed Ancestors a First-of-Its-Kind DNA Discovery Tool
13/03/2026
Reconstructed Ancestors sets a new industry standard to help reveal deeper family connections and fill gaps in a family tree with greater precision. PALO ALTO, Calif., March 13, 2026 (GLOBE NEWSWIRE) -- 23andMe , a [...]
Lifeward Receives Shareholder Approval to Close on Strategic Partnership with Oramed—Creating Diversified Biomedical Company
13/03/2026
Position s Lifeward as a diversified biomedical innovation company with clear path to profitability Integration of Oramed’s POD™ oral delivery technology expands Lifeward into biotech markets while Oramed funds the [...]
Sienna Announces March Dividend
13/03/2026
MARKHAM, Ontario, March 13, 2026 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) today announced a dividend of $0.078 per common share of the Company (each, a “ Common Share ”) [...]
Akari Therapeutics Releases CEO Corner Highlighting Strategic Progress and Path to Clinical Development Under CEO Abizer Gaslightwala
13/03/2026
Highlights strategic progress achieved under Abizer Gaslightwala’s leadership, including advancement of AKTX-101 and expansion of Akari’s ADC pipeline Access the Akari CEO Corner here TAMPA, Fla. and LONDON, March 13, [...]
CAPTAIN Trial Comparing Profound’s MRI-Guided TULSA Procedure™ to Robotic Radical Prostatectomy Successfully Meets Primary Safety Endpoint, Preservation of Erectile Function and Urinary Continence
13/03/2026
– First multicenter, randomized controlled trial directly comparing a new technology to robotic RP for men with localized prostate cancer to successfully recruit to target enrollment – – TULSA treatment demonstrates a [...]
TACTI-004 Phase III Study in First Line NSCLC to be discontinued following Futility Analysis
13/03/2026
Independent Data Monitoring Committee Recommends Discontinuation of Phase III Trial Following Futility Analysis SYDNEY, AUSTRALIA, March 13, 2026 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” [...]
Second Study Affirms Superiority of iMDx GraftAssure Assay’s Proprietary dd-cfDNA Combination Model Score
13/03/2026
New data supports GraftAssure commercialization efforts Multi-center study featured 249 biopsy-matched patients Proprietary “Combination Model” score outperformed percentage-only measures of dd-cfDNA Reinforces data [...]
Equillium Announces $35 Million Financing with RA Capital Management
13/03/2026
Capital strengthens the advancement of EQ504 through key clinical milestones Anticipated net proceeds, along with existing cash and cash equivalents, expected to extend cash runway into 2029 LA JOLLA, Calif., March 13, [...]
SPRINT® PNS System Now Covered Nationally by Aetna®
13/03/2026
- SPRINT PNS is now recognized as a covered treatment option when medically necessary for certain patients with intractable neuropathic pain - CLEVELAND, March 13, 2026 (GLOBE NEWSWIRE) -- SPR ® , a leading private [...]
SBC Medical to Announce Q4 and Full‑Year 2025 Financial Results
13/03/2026
IRVINE, Calif., March 13, 2026 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a Management Services Organization operating a wide range of franchise [...]

Pages